What Researchers Did
Researchers reviewed the rationale for hyperbaric oxygen therapy in transplantation, focusing on liver transplantation.
What They Found
The review found that hyperbaric oxygen (HBO) therapy influences ischemia, preservation, and reperfusion injury (IPRI) and subsequent acute cellular rejection. This therapy is explored as a way to mitigate post-transplantation organ dysfunction, especially when using marginal donor organs or advanced transplantation techniques.
What This Means for Canadian Patients
If hyperbaric oxygen therapy is successfully integrated into liver transplantation protocols, it could potentially improve organ function post-transplant for Canadian patients. This could lead to better outcomes, especially for those receiving marginal donor organs, and potentially increase the availability of life-saving transplants.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a review article, this study synthesizes existing literature and does not present new experimental data or clinical trial results.